Evidence map›Paper›PMID 34830285›Full record

ReviewInternational journal of molecular sciences2021

Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease.

Chengfei Xu, Ziling Liu, Jiangwei Xiao

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Journal of gastrointestinal oncology · 2025
    Article
  13. Review
  14. Autophagy: a double-edged sword in ischemia-reperfusion injury.Cellular & molecular biology letters · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chengfei XuDepartment of Gastrointestinal Surgery, Chengdu Medical College, Chengdu 610500, China.
Ziling LiuDepartment of Gastrointestinal Surgery, Chengdu Medical College, Chengdu 610500, China.
Jiangwei XiaoDepartment of Gastrointestinal Surgery, Chengdu Medical College, Chengdu 610500, China.
Chengdu Medical College · CN

Funding

National Natural Science Foundation of the P.R. of China No. 81070378 and No. 81270561Sichuan Outstanding Youth Fund Project Grant No. 2015JQ0060
6 · The paper itself

Abstract

Ferroptosis is a novel form of regulated cell death (RCD) that is typically accompanied by iron accumulation and lipid peroxidation. In contrast to apoptosis, autophagy, and necroptosis, ferroptosis has unique biological processes and pathophysiological characteristics. Since it was first proposed in 2012, ferroptosis has attracted attention worldwide. Ferroptosis is involved in the progression of multiple diseases and could be a novel therapeutic target in the future. Recently, tremendous progress has been made regarding ferroptosis and gastrointestinal diseases, including intestinal ischemia/reperfusion (I/R) injury, inflammatory bowel disease (IBD), gastric cancer (GC), and colorectal cancer (CRC). In this review, we summarize the recent progress on ferroptosis and its interaction with gastrointestinal diseases. Understanding the role of ferroptosis in gastrointestinal disease pathogenesis could provide novel therapeutic targets for clinical treatment.

Indexed as

FerroptosisAnimalsColorectal NeoplasmsFeeding BehaviorHumansInflammatory Bowel DiseasesIronLipid PeroxidationPhospholipidsPhytochemicalsPhytotherapyReperfusion InjuryStomach NeoplasmsTreatment OutcomeIronPhospholipidsPhytochemicalscolorectal cancerferroptosisgastric cancerinflammatory bowel diseaseischemia/reperfusion injury

Identifiers

PMID34830285
PMCPMC8620748
OpenAlexW3212931987

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.